IPR and Trademarks

BioStatus Group products are protected by a number of granted and pending patents and registered and pending trademarks that are cited on this website:

Registered or registration-pending patents of BioStatus Group include:

AU patent no 2005258935
EP patent no 1763673 (DK, FI, FR, DE, IE, IT, ES, SE, CH, NL, GB)
US patent no 7723085
US patent no 9759715
AU patent no 771378
CA patent no 2340670
EP patent no 1086178 (BE, DK, FI, FR, DE, GR, IE, IT, PT, ES, SE, CH, NL, GB)
JP patent no 4629871
US patent no 6468753
US patent no 7060427
US patent no 7605280
AU patent no 2011236610
AU patent no 2016250384
BR patent no 112012025820-6
CA patent no 2797440
CN patent no 201180028424.3
EP patent no 11720571.6
IN patent no 9321/CHENP/2012
JP patent no 6033767
JP patent no 2016-209377
KR patent no 10-2012-7029033
US patent no 9051467
US patent no 2015-0268142-A1
INT patent no PCT/GB2017/051702
INT patent no WO2014023956A1

Registered or registration-pending trademarks of BioStatus Group include:

BioStatus™, DRAQ™, DRAQ Deep Red AnthraQuinone™, DRAQ5™, DRAQ7™, DRAQ7 DROP & GO™, DRAQfx FIX & GO™, CyGEL™, CyGEL Sustain™, CyTRAK Orange™, APOPTRAK™, COMBITRAK™, HypoxiTRAK™, CyMORT Orange™, VIATRAK™

Registered or registration-pending trademarks of other companies:

• In-Cell Western™ is a trademark of LI-COR Biosciences.
• FACS™ is a trademark of Becton Dickinson & Company.